Therapeutic Peptide Attachment
Therapeutic Peptide Attachment - Related Videos
08:48
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
0 Views •
Cited by 10 •
2016
A simple and general method for the synthesis of cyclic peptides using microwave irradiation is outlined. This procedure enables the synthesis of backbone cyclic peptides with a collection of different conformations while retaining the side chains and the pharmacophoric moieties., and therefore, allows to screen for the bioactive conformation.
04:00
Immunoaffinity Based Extraction of Ubiquitinylated Peptides: A Technique to Selectively Extract Ubiquitin Tagged Peptides from Purified Peptide Fractions
0 Views •
2023
This video describes a method to extract and purify ubiquitinylated peptides containing remnant di-glycine peptides from a complex peptide mixture. The presented method may help in identifying original ubiquitination sites in the protein.
03:21
Peptide Purification: An RP-HPLC-based Technique to Extract Peptides from Digested Protein Lysates
0 Views •
2023
In this video, we demonstrate reversed-phase high-performance liquid chromatography to purify peptides from a digested protein lysate mixture. These purified peptides are then lyophilized and stored for downstream applications. Analysis of peptides can help understand the mechanics involved in cellular signaling and cancer.
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
0 Views •
Cited by 2 •
2013
Techniques to dissect the mechanisms underlying the secretion of HIV-1 Nef in exosomes are described. Specific short peptides derived from Nef and protein transfection were exploited to determine the structure, function, and binding partners of Nef’s Secretion Modification Region. These procedures have general relevance in many mechanistic studies.
01:20
Attachment
0 Views •
2025
Attachment is vital for infant development, as warm social interactions support growth and well-being. In a classic 1958 study by Harry Harlow, the significance of warmth and comfort in forming attachments was examined. Harlow separated newborn monkeys from their mothers and provided two artificial "mothers": one made of cold wire and the other covered in soft cloth. Despite the wire mother offering food, the infant monkeys preferred the comfort of the cloth mother, demonstrating that physical...
FAQs
Linker design and attachment location can determine whether a peptide remains active, is released at an appropriate stage, or interacts effectively with cells and tissues. Site-selective attachment helps control where the connection forms, while linker properties influence stability and release. Together, these choices can alter circulation behavior, biological activity, and the performance of the engineered therapeutic system.
Covalent attachment creates a chemical connection between the peptide and its partner, whereas noncovalent association relies on controlled molecular interactions. The choice depends on the desired balance of stability, release, and function. Covalent strategies can support more defined conjugates through linkers or reactive functional groups, while noncovalent systems may provide an alternative when reversible association is useful.
Reactive functional groups, the selected attachment site, and the linker provide the main points of control. Their arrangement determines how the peptide connects to a carrier, drug, or material and can influence whether its biological activity is preserved. Controlling these features also helps researchers tune release behavior and interactions with cells or tissues rather than treating attachment as a single fixed design.
A design typically begins by selecting the peptide's partner, such as a carrier, drug, or material, and then choosing a compatible linker or reactive functional group. Researchers next control the attachment chemistry and site selectivity, followed by evaluating stability, release, biological activity, circulation behavior, and cellular or tissue interactions. These considerations connect molecular design with the intended bioengineering outcome.
This approach is useful when a peptide needs improved delivery, stability, targeting, or function within an engineered system. Bioengineering applications include targeted drug-delivery platforms, biomaterials, biosensors, and peptide-based therapeutics. The attachment strategy can be adapted to the intended application by tuning how the peptide associates with its partner and how it behaves around cells or tissues.
Researchers can examine whether attachment improves delivery, stability, targeting, or function, while also assessing peptide release and retained biological activity. Additional outcomes include changes in circulation behavior and interactions with cells or tissues. These measurements show whether the selected chemistry, attachment site, and linker produce the intended performance rather than merely confirming that a connection formed.